SCHEMBL4837258

SCHEMBL4837258

Cc1ccc(S(=O)(=O)ON2C(=O)C3CC4C(=O)N(OS(=O)(=O)c5ccc(C)cc5)C(=O)C4CC3C2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.58
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 5/20 0.50
HPGD P15428 2/20 0.50
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PARL Q9H300 2/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 4/20 0.42
F2 P00734 3/20 0.42
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
MMP2 P08253 1/20 0.40
XBP1 P17861 1/20 0.38
HTT P42858 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5555744 0.88 VDR (0.55) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL5556606 0.87 POLB (0.49) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4831931 0.85 KMT2A (0.55) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4827161 0.85 VDR (0.63) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4826503 0.84 GAA (0.49) VDRALDH1A1SMN1; SMN2PARLMAPT
SCHEMBL4832240 0.84 KDM4E (0.50) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4837175 0.84 ALDH1A1 (0.50) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4830039 0.84 PARL (0.44) VDRALDH1A1KDM4EHPGDLMNA
SCHEMBL4837033 0.83 PARL (0.64) VDRALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL4833933 0.83 ALDH1A1 (0.59) VDRALDH1A1KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 VDR 4831/4885ALDH1A1 633/4885KDM4E 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.